ethacizine has been researched along with quinidine in 3 studies
| Studies (ethacizine) | Trials (ethacizine) | Recent Studies (post-2010) (ethacizine) | Studies (quinidine) | Trials (quinidine) | Recent Studies (post-2010) (quinidine) |
|---|---|---|---|---|---|
| 87 | 20 | 2 | 6,608 | 387 | 594 |
| Protein | Taxonomy | ethacizine (IC50) | quinidine (IC50) |
|---|---|---|---|
| Voltage-dependent L-type calcium channel subunit alpha-1F | Homo sapiens (human) | 6.4 | |
| Cholinesterase | Homo sapiens (human) | 1.23 | |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 10 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 3.32 | |
| Cytochrome P450 2D26 | Rattus norvegicus (Norway rat) | 2.8 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.3532 | |
| Potassium voltage-gated channel subfamily A member 5 | Homo sapiens (human) | 7.3 | |
| Cholinesterase | Equus caballus (horse) | 7.37 | |
| Voltage-dependent L-type calcium channel subunit alpha-1D | Homo sapiens (human) | 6.4 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.7882 | |
| Voltage-dependent L-type calcium channel subunit alpha-1S | Homo sapiens (human) | 6.4 | |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | 6.4 | |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 6.9 | |
| Potassium voltage-gated channel subfamily D member 2 | Rattus norvegicus (Norway rat) | 2.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Skibitskiĭ, VV | 1 |
| Denisiuk, VI; Kotsuta, GI; Lipnitskiĭ, TN; Stepaniuk, AV | 1 |
| Scamps, F; Undrovinas, A; Vassort, G | 1 |
3 other study(ies) available for ethacizine and quinidine
| Article | Year |
|---|---|
[The potentials of combined anti-arrhythmia therapy with the use of neuroactive amino acids in patients with ischemic heart disease].
Topics: Aged; Angina Pectoris; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Complexes, Premature; Drug Evaluation; Drug Therapy, Combination; Glutamates; Glutamic Acid; Hemodynamics; Humans; Middle Aged; Myocardial Ischemia; Phenothiazines; Physical Exertion; Quinidine; Succinates; Succinic Acid | 1992 |
[Clinical efficacy of combined therapy with verapamil and fast sodium channel blockers for refractory atrial fibrillation].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Therapy, Combination; Humans; Middle Aged; Moricizine; Phenothiazines; Procainamide; Quinidine; Sodium Channels; Verapamil | 1991 |
Inhibition of ICa in single frog cardiac cells by quinidine, flecainide, ethmozin, and ethacizin.
Topics: Animals; Anti-Arrhythmia Agents; Calcium Channels; Flecainide; Heart; In Vitro Techniques; Membrane Potentials; Moricizine; Phenothiazines; Quinidine; Rana esculenta | 1989 |